litlas
Log inCreate account

A. Zink

Active 1996–2024

Also published as
A Zink
83
Papers
19,112
Citations
65
h-index
81
i10-index

Citations

Citations per year for A. Zink1987: 2 citations1996: 1 citations1997: 8 citations1998: 4 citations1999: 6 citations2000: 3 citations2001: 5 citations2002: 26 citations2003: 43 citations2004: 60 citations2005: 111 citations2006: 99 citations2007: 104 citations2008: 114 citations2009: 107 citations2010: 135 citations2011: 186 citations2012: 133 citations2013: 143 citations2014: 151 citations2015: 155 citations2016: 110 citations2017: 141 citations2018: 128 citations2019: 547 citations2020: 532 citations2021: 402 citations2022: 323 citations2023: 228 citations2024: 449 citations2025: 136 citations2026: 7 citations1988–1995: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,229 citing papers, 15.5% of this breakdownUnited Kingdom: 722 citing papers, 9.1% of this breakdownGermany: 719 citing papers, 9.1% of this breakdownNetherlands: 470 citing papers, 5.9% of this breakdownItaly: 425 citing papers, 5.4% of this breakdownFrance: 378 citing papers, 4.8% of this breakdownCanada: 362 citing papers, 4.6% of this breakdownSpain: 281 citing papers, 3.5% of this breakdownChina: 242 citing papers, 3% of this breakdownSwitzerland: 236 citing papers, 3% of this breakdownJapan: 225 citing papers, 2.8% of this breakdownSweden: 202 citing papers, 2.5% of this breakdown
0%15.5%Other 30.8%

Institutions

Fields

  • Medicine87%
  • Immunology and Microbiology5.1%
  • Biochemistry, Genetics and Molecular Biology4%
  • Engineering0.9%
  • Health Professions0.7%
  • Neuroscience0.4%
  • Other1.9%

Topics

  • Rheumatoid Arthritis Research and Therapies19.4%
  • Spondyloarthritis Studies and Treatments12.1%
  • Autoimmune and Inflammatory Disorders Research6.3%
  • Systemic Lupus Erythematosus Research4.8%
  • Psoriasis: Treatment and Pathogenesis4.2%
  • Pregnancy and Medication Impact2.2%
  • Other51%

Coauthors

All papers

Open in search
  1. EULAR definition of difficult-to-treat rheumatoid arthritis

    Authors: György Nagy, Nadia M T Roodenrijs, Paco M J Welsing, Melinda Kedves, Attila Hamar, Marlies C. van der Goes, Alison Kent, Margôt Bakkers, Etienne Blaas, Ladislav Šenolt, Zoltán Szekanecz, Ernest Choy, Maxime Dougados, Johannes W. G. Jacobs, Rinie Geenen, Hans Bijlsma, A. Zink, Daniel Aletaha, Leonard Schoneveld, Piet L. C. M. van Riel, Loriane Gutermann, Yeliz Prior, Elena Nikiphorou, Gianfranco Ferraccioli, Georg Schett, Kimme L Hyrich, Ulf Müeller-Ladner, Maya H Buch, Iain B. McInnes, Désirée van der Heijde, Jacob M. van Laar - Annals of the Rheumatic Diseases 2020 cited by 539

  2. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation

    Authors: Carina Gøtestam Skorpen, Maria Hoeltzenbein, Anǵela Tincani, Rebecca Fischer‐Betz, Élisabeth Éléfant, Christina Chambers, José António Pereira da Silva, Catherine Nelson‐Piercy, Irene Cetin, N. Costedoat‐Chalumeau, Radboud J. E. M. Dolhain, Frauke Förger, Munther A. Khamashta, Guillermo Ruiz‐Irastorza, A. Zink, Jiří Vencovský, Maurizio Cutolo, N. Caeyers, Claudia Zumbühl, Monika Østensen - Annals of the Rheumatic Diseases 2016 cited by 1,058

  3. EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis

    Authors: György Nagy, Nadia M T Roodenrijs, Paco M J Welsing, Melinda Kedves, Attila Hamar, Marlies C. van der Goes, Alison Kent, Margôt Bakkers, Polina Pchelnikova, Etienne Blaas, Ladislav Šenolt, Zoltán Szekanecz, Ernest Choy, Maxime Dougados, Johannes W. G. Jacobs, Rinie Geenen, J. W. J. Bijlsma, A. Zink, Daniel Aletaha, Leonard Schoneveld, Piet L. C. M. van Riel, Sophie Dumas, Yeliz Prior, Elena Nikiphorou, Gianfranco Ferraccioli, Georg Schett, Kimme L Hyrich, Ulf Müeller-Ladner, Maya H Buch, Iain B. McInnes, Désirée van der Heijde, Jacob M. van Laar - Annals of the Rheumatic Diseases 2021 cited by 276

  4. Dose-related patterns of glucocorticoid-induced side effects

    Authors: Dörte Huscher, K. Thiele, Erika Gromnica‐Ihle, Gert Hein, W. Demary, R. Dreher, A. Zink, Frank Buttgereit - Annals of the Rheumatic Diseases 2008 cited by 582

  5. American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials

    Authors: David T. Felson, Josef S Smolen, George A. Wells, Bin Zhang, L. van Tuyl, Julia Funovits, Daniel Aletaha, Cornelia F Allaart, Joan M. Bathon, Stefano Bombardieri, Peter Brooks, Andrew Brown, Marco Matucci‐Cerinic, Hyon K. Choi, Bernard Combe, Maarten de Wit, Maxime Dougados, Paul Emery, Daniel E. Furst, Juan J. Gómez‐Reino, Gillian Hawker, Edward Keystone, Dinesh Khanna, John Kirwan, Tore K Kvien, Robert Landewé, Joachim Listing, Kaleb Michaud, E. Martín‐Mola, Pamela Montie, Theodore Pincus, Pamela Richards, Jeffrey N. Siegel, Lee S. Simon, Tuulikki Sokka, Vibeke Strand, Peter Tugwell, Alan Tyndall, Desirée van der Heijde, Suzanne Verstappen, Barbara White, Frederick Wolfe, A. Zink, Maarten Boers - Annals of the Rheumatic Diseases 2011 cited by 1,019

  6. The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment

    Authors: Joachim Listing, Kerstin Gerhold, A. Zink - Lara D. Veeken 2012 cited by 542

  7. Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNFα inhibitors and rituximab

    Authors: Joachim Listing, Jörn Kekow, Bernhard Manger, Gerd‐Rüdiger Burmester, Dagmar Pattloch, A. Zink, Anja Strangfeld - Annals of the Rheumatic Diseases 2013 cited by 288

  8. Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial

    Authors: Jürgen Braun, J. Brandt, Joachim Listing, A. Zink, Rieke Alten, W. Golder, E Gromnica-lhle, H. Kellner, Andreas Krause, Matthias Schneider, H. Sörensen, H. Zeidler, Wolfgang Thriene, Joachim Sieper - The Lancet 2002 cited by 1,266

  9. European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update

    Authors: Laure Gossec, Josef S Smolen, Sofía Ramiro, M. De Wit, Maurizio Cutolo, Maxime Dougados, Paul Emery, R. Landewé, Susan Oliver, Daniel Aletaha, Neil Betteridge, Jürgen Braun, Gerd R Burmester, Juan D. Cañete, Nemanja Damjanov, Oliver FitzGerald, Emma Haglund, Philip Helliwell, T. K. Kvien, Rik Lories, Thomas A. Luger, Mara Maccarone, Helena Marzo‐Ortega, Dennis McGonagle, Iain B. McInnes, Ignazio Olivieri, Karel Pavelká, Georg Schett, Joachim Sieper, Filip Van den Bosch, Douglas J. Veale, J. Wollenhaupt, A. Zink, Désirée van der Heijde - Annals of the Rheumatic Diseases 2016 cited by 913

  10. Risk of herpes zoster (shingles) in patients with rheumatoid arthritis under biologic, targeted synthetic and conventional synthetic DMARD treatment: data from the German RABBIT register

    Authors: Imke Redeker, Katinka Albrecht, Joern Kekow, Gerd R Burmester, Jürgen Braun, Martin Schäfer, A. Zink, Anja Strangfeld - Annals of the Rheumatic Diseases 2021 cited by 92

  11. Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient?

    Authors: Anja Strangfeld, Maria Eveslage, Matthias Schneider, H. J. Bergerhausen, T. Klopsch, A. Zink, Joachim Listing - Annals of the Rheumatic Diseases 2011 cited by 362

  12. Determinants of diagnostic delay in axial spondyloarthritis: an analysis based on linked claims and patient-reported survey data

    Authors: Imke Redeker, Johanna Callhoff, Falk Hoffmann, Hildrun Haibel, Joachim Sieper, A. Zink, Denis Poddubnyy - Lara D. Veeken 2019 cited by 152

  13. Ankylosing spondylitis: an overview

    Authors: Joachim Sieper, Jürgen Braun, Martín Rudwaleit, Annelies Boonen, A. Zink - Annals of the Rheumatic Diseases 2002 cited by 660

  14. Risk of incident or recurrent malignancies among patients with rheumatoid arthritis exposed to biologic therapy in the German biologics register RABBIT

    Authors: Anja Strangfeld, Franka Hierse, Rolf Rau, Gerd‐Ruediger Burmester, Brigitte Krummel-Lorenz, W. Demary, Joachim Listing, A. Zink - Arthritis Research & Therapy 2010 cited by 262

  15. Risk for lower intestinal perforations in patients with rheumatoid arthritis treated with tocilizumab in comparison to treatment with other biologic or conventional synthetic DMARDs

    Authors: Anja Strangfeld, Adrian Richter, Britta Siegmund, P. Herzer, Karin Rockwitz, W. Demary, Martin Aringer, Yvette Meißner, A. Zink, Joachim Listing - Annals of the Rheumatic Diseases 2016 cited by 193

  16. EULAR recommendations for a core data set for pregnancy registries in rheumatology

    Authors: Yvette Meißner, Rebecca Fischer‐Betz, Laura Andréoli, N. Costedoat‐Chalumeau, Diederik De Cock, Radboud J. E. M. Dolhain, Frauke Förger, Doreen Goll, Anna Moltó, Catherine Nelson‐Piercy, Rebecca Özdemir, Luigi Raio, S. C. Rodriguez-García, Savino Sciascia, Marianne Wallenius, Astrid Zbinden, A. Zink, Anja Strangfeld - Annals of the Rheumatic Diseases 2020 cited by 83

  17. Points to consider for reporting, screening for and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: a EULAR initiative

    Authors: Athan Baillet, Laure Gossec, Loreto Carmona, Maarten de Wit, Yvonne van Eijk‐Hustings, Heidi Bertheussen, Kent Alison, Mette Toft, Marios Kouloumas, Ricardo J O Ferreira, Susan Oliver, Andrea Rubbert‐Roth, Sander van Assen, William G Dixon, Axel Finckh, A. Zink, Joel M. Kremer, Tore K Kvien, Michael T. Nurmohamed, Désirée van der Heijde, Maxime Dougados - Annals of the Rheumatic Diseases 2016 cited by 256

  18. Infections in patients with rheumatoid arthritis treated with biologic agents

    Authors: Joachim Listing, Anja Strangfeld, S. Kary, Rolf Rau, U von Hinueber, Maria Stoyanova‐Scholz, Erika Gromnica‐Ihle, Christian Antoni, P. Herzer, Jörn Kekow, Matthias Schneider, A. Zink - Arthritis & Rheumatism 2005 cited by 687

  19. Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers

    Authors: Louise Mercer, Johan Askling, Pauline Raaschou, William G Dixon, Lene Dreyer, Merete Lund Hetland, Anja Strangfeld, A. Zink, Xavier Mariette, Axel Finckh, Helena Canhão, Florenzo Iannone, Jakub Závada, Jacques Morel, Jacques‐Eric Gottenberg, Kimme L Hyrich, Joachim Listing - Annals of the Rheumatic Diseases 2016 cited by 188

  20. Prevalence and treatment of hip and knee osteoarthritis in people aged 60 years or older in Germany: an analysis based on health insurance claims data

    Authors: Anne Postler, Andres Luque Ramos, Jens Goronzy, Klaus‐Peter Günther, Toni Lange, Jochen Schmitt, A. Zink, Falk Hoffmann - Clinical Interventions in Aging 2018 cited by 183

  21. Determinants of psychological well-being in axial spondyloarthritis: an analysis based on linked claims and patient-reported survey data

    Authors: Imke Redeker, Falk Hoffmann, Johanna Callhoff, Hildrun Haibel, Joachim Sieper, A. Zink, Denis Poddubnyy - Annals of the Rheumatic Diseases 2018 cited by 81

  22. Positioning of total knee arthroplasty with and without navigation support

    Authors: M. Sparmann, B. Wolke, H. Czupalla, D. Banzer, A. Zink - Journal of Bone and Joint Surgery - British Volume 2003 cited by 518

  23. Efficacy of TNFα blockers in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a meta-analysis

    Authors: Johanna Callhoff, Joachim Sieper, Anja Weiß, A. Zink, Joachim Listing - Annals of the Rheumatic Diseases 2014 cited by 213

  24. Does tumor necrosis factor α inhibition promote or prevent heart failure in patients with rheumatoid arthritis?

    Authors: Joachim Listing, Anja Strangfeld, Jörn Kekow, Matthias Schneider, A Kapelle, Siegfried Wassenberg, A. Zink - Arthritis & Rheumatism 2008 cited by 195